[
  {
    "structure_id": "PDB:8OOI",
    "protein": "VCP/p97",
    "full_name": "Valosin-containing protein (VCP/p97 AAA+ ATPase)",
    "gene": "VCP",
    "method": "Cryo-EM",
    "resolution": "2.9 Å",
    "conformation": "ADP-bound hexamer",
    "organism": "Homo sapiens",
    "variant_context": "Wild-type VCP hexamer structure - reference for FTD-linked mutations",
    "binding_sites": ["D1 ATPase domain", "D2 ATPase domain", "N-terminal domain"],
    "druggable_pockets": ["Allosteric pocket between D1-D2 interface", "ATP binding site"],
    "source": "RCSB PDB / Cryo-EM",
    "pdb_url": "https://www.rcsb.org/structure/8OOI",
    "image_url": "https://cdn.rcsb.org/images/structures/oo/8ooi/8ooi_assembly-1.jpeg",
    "emdb_id": "EMD-36540",
    "emdb_image_url": "https://www.ebi.ac.uk/emdb/images/entry/EMD-36540/400_36540.gif",
    "summary_text": "High-resolution Cryo-EM structure of human VCP/p97 hexamer in ADP-bound state reveals the quaternary architecture and domain organization of this AAA+ ATPase. The structure provides critical context for understanding how FTD-associated mutations at positions like R159H disrupt the N-D1 domain interface and impair protein quality control functions. The D1-D2 domain interface represents a druggable allosteric site for potential small-molecule inhibitors."
  },
  {
    "structure_id": "PDB:9DIL",
    "protein": "VCP/p97 with cofactor",
    "full_name": "VCP-p47 complex",
    "gene": "VCP",
    "method": "Cryo-EM",
    "resolution": "3.2 Å",
    "conformation": "Cofactor-bound state",
    "organism": "Homo sapiens",
    "variant_context": "VCP with cofactor binding - relevant for understanding adaptor interactions",
    "binding_sites": ["N-terminal domain cofactor site", "UBX domain interface"],
    "druggable_pockets": ["Cofactor displacement site", "N-domain groove"],
    "source": "RCSB PDB / Cryo-EM",
    "pdb_url": "https://www.rcsb.org/structure/9DIL",
    "image_url": "https://cdn.rcsb.org/images/structures/di/9dil/9dil_assembly-1.jpeg",
    "emdb_id": "EMD-19622",
    "emdb_image_url": "https://www.ebi.ac.uk/emdb/images/entry/EMD-19622/400_19622.gif",
    "summary_text": "Cryo-EM structure of VCP/p97 bound to cofactor reveals the molecular basis for adaptor protein recruitment. This structure is important for FTD research as disease mutations can disrupt cofactor binding and alter substrate processing. The cofactor interface represents a potential site for therapeutic intervention."
  },
  {
    "structure_id": "PDB:7K56",
    "protein": "VCP/p97 D2 domain",
    "full_name": "VCP D2 ATPase domain",
    "gene": "VCP",
    "method": "Cryo-EM",
    "resolution": "2.4 Å",
    "conformation": "ATP-bound active state",
    "organism": "Homo sapiens",
    "variant_context": "Active D2 domain - mechanical force generation for protein unfolding",
    "binding_sites": ["D2 ATP binding pocket", "Central pore"],
    "druggable_pockets": ["D2 nucleotide binding site"],
    "source": "RCSB PDB / Cryo-EM",
    "pdb_url": "https://www.rcsb.org/structure/7K56",
    "image_url": "https://cdn.rcsb.org/images/structures/k5/7k56/7k56_assembly-1.jpeg",
    "emdb_id": "EMD-22890",
    "emdb_image_url": "https://www.ebi.ac.uk/emdb/images/entry/EMD-22890/400_22890.gif",
    "summary_text": "High-resolution structure of the VCP D2 ATPase domain captures the ATP-bound catalytically active state responsible for generating mechanical force to unfold substrate proteins. The D2 domain is essential for VCP's protein quality control function, and inhibitors targeting this domain could modulate VCP activity in FTD contexts."
  },
  {
    "structure_id": "PDB:5FTK",
    "protein": "VCP/p97 with inhibitor CB-5083",
    "full_name": "VCP-inhibitor complex",
    "gene": "VCP",
    "method": "X-ray crystallography",
    "resolution": "2.3 Å",
    "conformation": "Inhibitor-bound state",
    "organism": "Homo sapiens",
    "variant_context": "Drug-bound structure - template for structure-based drug design",
    "binding_sites": ["D2 ATP-competitive site"],
    "druggable_pockets": ["CB-5083 binding pocket"],
    "inhibitor": "CB-5083",
    "inhibitor_smiles": "CC(C)C1=C(C=C(C=C1)NC2=NC3=C(C=N2)N(C=C3)C)C(=O)NC4=CC=C(C=C4)CN5CCOCC5",
    "source": "RCSB PDB / X-ray",
    "pdb_url": "https://www.rcsb.org/structure/5FTK",
    "image_url": "https://cdn.rcsb.org/images/structures/ft/5ftk/5ftk_assembly-1.jpeg",
    "summary_text": "Crystal structure of VCP bound to the ATP-competitive inhibitor CB-5083 reveals the molecular basis for small-molecule inhibition of this AAA+ ATPase. This structure provides a template for structure-based design of next-generation VCP modulators that could be developed for frontotemporal dementia. The inhibitor occupies the D2 nucleotide binding site, blocking ATP hydrolysis and substrate processing."
  }
]
